AUBREY MOLGAARD: Open Payments
NPI 1427597806 · AMES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$87,318 in 192 payments from 13 companies in 2025. Trend: 2023 $9,700 · 2024 $140,223 · 2025 $87,318
Speaker / faculty: $48,613Travel & lodging: $28,955Food & beverage: $6,108Honoraria: $3,600Education: $43
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 130 | $80,579 |
| Xeris Pharmaceuticals, Inc. | 14 | $3,947 |
| Sequel Med Tech, LLC | 11 | $1,705 |
| Insulet Corporation | 9 | $303 |
| Dexcom, Inc. | 9 | $236 |
| Amgen Inc. | 6 | $208 |
| Mannkind Corporation | 4 | $190 |
| Novo Nordisk Inc | 2 | $37 |
| Medtronic, Inc. | 2 | $33 |
| Inspire Medical Systems, Inc. | 1 | $26 |
Products named: TZIELD, GVOKE HYPOPEN, TWIIST, Omnipod, Dexcom G6 Transmitter, AFREZZA, REPATHA, KRYSTEXXA.
Industry payments across IA — which companies pay providers there.
